非创伤性降主动脉破裂:TEVAR与开放手术中期结局比较
单中心回顾性研究纳入1999至2018年118例非创伤性降主动脉破裂患者,比较TEVAR(79例)与开放手术(39例)的结局。TEVAR组30天死亡率(16.5%对38.5%,P=.01)及卒中、永久性脊髓缺血、延长通气、气管切开等并发症均显著更低,末次随访全因死亡率亦更低(35.4%对66.7%,P=.001)。多因素分析显示TAAA是死亡独立预测因素。
要点
- TEVAR较开放手术显著降低30天死亡率(16.5%对38.5%,P=.01)。
- TEVAR组卒中、永久性脊髓缺血、延长通气及气管切开率均显著更低。
- TEVAR组末次随访全因死亡率更低(35.4%对66.7%,P=.001)。
核心结论
- TEVAR较开放手术改善非创伤性降主动脉破裂的早期和中期结局。
- TAAA是死亡的独立预测因素。
- 腔内修复可能为DTAR提供最大的生存机会。
研究设计与样本
- 单中心回顾性研究,1999年12月至2018年10月纳入118例DTAR患者。
- 开放手术组39例,TEVAR组79例。
- 主要终点为30天和长期全因死亡率。
主要发现
- 30天死亡率TEVAR组16.5%,开放手术组38.5%(P=.01)。
- 卒中发生率TEVAR组3.8%,开放手术组15.6%(P=.03)。
- 永久性脊髓缺血TEVAR组2.5%,开放手术组15.6%(P=.02)。
- 延长通气TEVAR组8.9%,开放手术组30.8%(P=.002)。
- 末次随访全因死亡率TEVAR组35.4%,开放手术组66.7%(P=.001)。
关键数值与推荐
- 气管切开率TEVAR组2.5%,开放手术组12.8%(P=.04)。
- 需血液透析率开放手术组12.8%,TEVAR组5.1%(P=.2)。
- 30天内主动脉再干预TEVAR组15.2%,开放手术组2.6%(P=.06)。
临床怎么用
- 对非创伤性降主动脉破裂,可优先考虑TEVAR以降低早期死亡和并发症。
- 合并TAAA者死亡风险更高,需加强风险评估与围术期管理。
局限性
- 单中心回顾性设计,样本量有限。
- 随访时间差异较大(开放手术组1048±1591天,TEVAR组828±1258天)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) has become first-line treatment for descending thoracic aortic rupture (DTAR), but its midterm and long-term outcomes remain undescribed. This study evaluated whether TEVAR would improve midterm outcomes of nontraumatic DTAR relative to open surgical repair (OSR). METHODS: Between December 1999 and October 2018, 118 patients with DTAR were treated with either OSR (n = 39) or TEVAR (n = 79) at a single center. Primary end points were 30-day and long-term all-cause mortalities. Secondary end points included stroke, permanent spinal cord ischemia (SCI), prolonged ventilation support or tracheostomy, permanent hemodialysis, and aortic reintervention. RESULTS: Thirty-day mortality was significantly lower with TEVAR (OSR, 38.5%; TEVAR, 16.5%; P = .01). Stroke (15.6% vs 3.8%; P = .03), permanent SCI (15.6% vs 2.5%; P = .02), prolonged ventilation (30.8% vs 8.9%; P = .002), and tracheostomy (12.8% vs 2.5%; P = .04) were significantly lower after TEVAR than OSR. Need for hemodialysis trended higher after OSR (12.8% vs 5.1%; P = .2). Mean follow ups were 1048 ± 1591 days for OSR group and 828 ± 1258 days for TEVAR. All-cause mortality at last follow-up was significantly lower after TEVAR than OSR (35.4% vs 66.7%; P = .001). Aortic reintervention was required more frequently within 30 days after TEVAR (15.2% vs 2.6%; P = .06). By multivariate analysis, TAAA was an independent predictor for mortality. CONCLUSIONS: TEVAR improves both early and midterm outcomes of DTAR relative to OSR. TAAA was a predictor of mortality. Endovascular approach to DTAR may provide the greatest chance at survival.
引用
- Ogawa Y, Watkins AC, Lingala B, et al. Improved midterm outcomes after endovascular repair of nontraumatic descending thoracic aortic rupture compared with open surgery. J Thorac Cardiovasc Surg. 2019. PMID: 31926735. doi:10.1016/j.jtcvs.2019.10.156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。